Induction Healthcare Group PLC
LSE:INHC
Intrinsic Value
Induction Healthcare Group Plc operates as a healthcare technology company. [ Read More ]
The intrinsic value of one
INHC
stock under the Base Case scenario is
37.35
GBX.
Compared to the current market price of 12.5 GBX,
Induction Healthcare Group PLC
is
Undervalued by 67%.
Induction Healthcare Group PLC's market capitalization is 11.5m GBX.
INHC stock price is 12.5 GBX.
INHC stock price (12.5 GBX) is 67% less than its Intrinsic Value (37.35 GBX).
INHC stock price (12.5 GBX) is 65% less than its Relative Value (35.77 GBX). Open Relative Valuation
INHC has upside potential of 145% compared to the average analyst price target.
Open Wall St Estimates
INHC's ROE (Return on Equity) has increased in the last 3 years from -53% to -48%, and is approaching profitability.
INHC's Revenue has grown by an exceptional 21% over the past 12 months.
INHC's short-term assets (10m GBP) exceed its short-term liabilties (8m GBP).
INHC's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from -59% to -37%, and is approaching profitability.
INHC has negative Operating Income for the last twelve months.
INHC has negative Net Income for the last twelve months.
INHC's ROE (Return on Equity) for the past 12 months is negative and is equal to -48%.
INHC's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -37%.
INHC has positive Gross Profit for the last twelve months.
INHC's long-term assets (34m GBP) exceed its long-term liabilties (12m GBP).
INHC has negative Free Cash Flow for the last twelve months.
INHC's Revenue has been growing by an exceptional 153% per year for the last 3 years.
INHC has negative three-year average ROE (Return on Equity): -37%. The company is not efficient at transforming stockholders' equity into net income.
INHC has negative three-year average ROIC (Return on Invested Capital): -35%. The company is not efficient at using invested capital to generate operating income.
INHC's D/E (Debt to Equity) is very low and is equal to 0.
INHC's Altman Z-Score is very low and is equal to -1.18.
INHC doesn't generate enough operating income (-15m GBP) to safely cover interest payments on its debt (5k GBP).
Valuation Backtest
Induction Healthcare Group PLC
Run backtest to discover the historical profit from buying and selling
INHC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Induction Healthcare Group PLC
Balance Sheet Decomposition
Induction Healthcare Group PLC
| Current Assets | 10.1m |
| Cash & Short-Term Investments | 3.9m |
| Receivables | 3.5m |
| Other Current Assets | 2.8m |
| Non-Current Assets | 24.2m |
| PP&E | 7k |
| Intangibles | 23.7m |
| Other Non-Current Assets | 552k |
| Current Liabilities | 7.9m |
| Accounts Payable | 509k |
| Accrued Liabilities | 1.4m |
| Other Current Liabilities | 6m |
| Non-Current Liabilities | 3.8m |
| Other Non-Current Liabilities | 3.8m |
Earnings Waterfall
Induction Healthcare Group PLC
|
Revenue
|
11.8m
GBP
|
|
Cost of Revenue
|
-3.9m
GBP
|
|
Gross Profit
|
8m
GBP
|
|
Operating Expenses
|
-23.3m
GBP
|
|
Operating Income
|
-15.3m
GBP
|
|
Other Expenses
|
1.1m
GBP
|
|
Net Income
|
-14.2m
GBP
|
Free Cash Flow Analysis
Induction Healthcare Group PLC
What is Free Cash Flow?
INHC Profitability Score
Profitability Due Diligence
Induction Healthcare Group PLC's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
Score
Induction Healthcare Group PLC's profitability score is 32/100. The higher the profitability score, the more profitable the company is.
INHC Solvency Score
Solvency Due Diligence
Induction Healthcare Group PLC's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Induction Healthcare Group PLC's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
INHC Price Targets Summary
Induction Healthcare Group PLC
According to Wall Street analysts, the average 1-year price target for
INHC
is 30.6 GBX
with a low forecast of 30.3 GBX and a high forecast of 31.5 GBX.
Shareholder Return
INHC Price
Induction Healthcare Group PLC
| Average Annual Return | -30.95% |
| Standard Deviation of Annual Returns | 22.62% |
| Max Drawdown | -90% |
| Market Capitalization | 11.5m GBX |
| Shares Outstanding | 92 298 800 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Induction Healthcare Group PLC
Country
Industry
Market Cap
Dividend Yield
Description
Induction Healthcare Group Plc operates as a healthcare technology company. The Company’s platforms include Induction Switch, Induction Zesty, Induction Booking, Induction Guidance, Induction HealthStream, Induction OPAT and Induction Attend Anywhere. Induction Switch is a healthcare collaboration application in the United Kingdom, used by the majority of hospital doctors within the National Health Service (NHS). Induction Zesty is a software-as-a-service (SaaS) platform that acts as a digital front door for patients visiting hospitals. Induction Booking offers NHS Trusts and other healthcare organizations an online booking platform for patients, hospital staff and care home staff. Induction Guidance provides medical organizations, including hospital trusts within the NHS, with the ability to collaboratively create, edit and publish their own local medical guidelines in an administrated environment.
Contact
IPO
Employees
Officers
The intrinsic value of one
INHC
stock under the Base Case scenario is
37.35
GBX.
Compared to the current market price of 12.5 GBX,
Induction Healthcare Group PLC
is
Undervalued by 67%.
You don't have any saved screeners yet
